Name | ethyl 3-methyl-2-nitroimidazole-4-carboxylate |
---|---|
Synonyms |
5-carbethoxy-1-methyl-2-nitroimidazole
ETHYL 3-METHYL-2-NITRO-3H-IMIDAZOLE-4-CARBOXYLATE 1-N-methyl-2-nitroimidazole-5-carboxylic acid ethyl ester 5-Carbethoxy-1-methyl-2-nitro-imidazol 3-methyl-2-nitro-3H-imidazole-4-carboxylic acid ethyl ester 1-Methyl-2-nitro-5-carbethoxy-imidazol 1-methyl-2-nitro-1H-imidazole-5-carboxylate |
Density | 1.42g/cm3 |
---|---|
Boiling Point | 379.2ºC at 760 mmHg |
Molecular Formula | C7H9N3O4 |
Molecular Weight | 199.16400 |
Flash Point | 183.1ºC |
Exact Mass | 199.05900 |
PSA | 89.94000 |
LogP | 1.02820 |
Index of Refraction | 1.584 |
HS Code | 2933290090 |
---|
~60% 39070-13-8 |
Literature: THRESHOLD PHARMACEUTICALS, INC. Patent: WO2007/2931 A2, 2007 ; Location in patent: Page/Page column 141-142 ; |
Precursor 1 | |
---|---|
DownStream 2 | |
HS Code | 2933290090 |
---|---|
Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |